---
title: "CLOUDR 2025 Mid-term Performance Briefing: Operating Cash Flow Turns Positive for the First Time, P2M Business Grows by 142.1%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/254838727.md"
description: "On August 27th, CLOUDR released its semi-annual performance: same-caliber revenue of 890 million yuan, a year-on-year increase of 20.3%; adjusted gross margin increased by 29.3 percentage points year-on-year to 49.9%, and net loss narrowed by 23.3%; operating cash flow turned positive historically, with a net inflow of 28.65 million yuan (compared to a net outflow of 195 million yuan in the same period last year). Revenue from P2M solutions was 260 million yuan with profitability, a year-on-year increase of 142.1%; six core products have been launched, and eight new products are queued for launch. The AI dual model (ClouD GPT/DTx) has completed the data-monetization closed loop, and the gestational diabetes solution has been published in an international journal; the company's SaaS has covered over 2,700 hospitals and nearly 270,000 pharmacies. Management stated that they will accelerate the commercialization of P2M and consolidate their leading position in chronic disease digitalization"
datetime: "2025-08-27T13:54:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254838727.md)
  - [en](https://longbridge.com/en/news/254838727.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254838727.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/254838727.md) | [English](https://longbridge.com/en/news/254838727.md)


# CLOUDR 2025 Mid-term Performance Briefing: Operating Cash Flow Turns Positive for the First Time, P2M Business Grows by 142.1%

According to Zhitong Finance APP, on August 27, CLOUDR (09955) released its semi-annual performance: same-caliber revenue of 890 million yuan, a year-on-year increase of 20.3%; adjusted gross margin increased by 29.3 percentage points year-on-year to 49.9%, and net loss narrowed by 23.3%; operating cash flow turned positive historically, with a net inflow of 28.65 million yuan (compared to a net outflow of 195 million yuan in the same period last year).

P2M solution revenue was 260 million yuan and profitable, a year-on-year increase of 142.1%; six core products have been launched, and eight new products are queued for launch. The AI dual model (ClouD GPT/DTx) has completed the data-monetization closed loop, and the gestational diabetes solution has been published in an international journal; the company's SaaS has covered over 2,700 hospitals and nearly 270,000 pharmacies. Management stated that it will accelerate the commercialization of P2M and consolidate its leading position in chronic disease digitalization

### 相關股票

- [CLOUDR (09955.HK)](https://longbridge.com/zh-HK/quote/09955.HK.md)

## 相關資訊與研究

- [WuXi XDC Cayman, Inc. (2268) Receives a Buy from Orient Securities](https://longbridge.com/zh-HK/news/280931364.md)
- [Miraval Resorts & Spas and Humin Set New Standard for the Future of Measurable Wellness with Groundbreaking New Study | H Stock News](https://longbridge.com/zh-HK/news/281216315.md)
- [11:33 ETFitness, Health and Wellness Experts Team Up to 'Get Fit for No Kid Hungry' with New On-Demand Initiative](https://longbridge.com/zh-HK/news/281213207.md)
- [ASIA COFFEE-Domestic prices edge lower in Vietnam amid slow trade, thin demand](https://longbridge.com/zh-HK/news/281490266.md)
- [07:35 ETLucky Energy Expands Its Beverage Line with SLUSH, Introducing Three New Flavors in a 12-oz Sleek Can](https://longbridge.com/zh-HK/news/281516216.md)